Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Forward Pharma A/S | - | - | - | - | - | - | - |
F-Star Therapeutics Inc. | 18.750% | - | - | - | - | - | - |
Fuji Pharma Co. Ltd. | 0.550% | 0.546% | -6.122% | 12.195% | -17.117% | 1.099% | -29.931% |
Futura Medical | - | 1.538% | -6.161% | -25.981% | 45.588% | -28.649% | - |
G1 Therapeutics | -6.500% | -5.852% | -9.900% | 38.084% | 31.055% | -80.676% | - |
Galapagos N.V. | 0.980% | -1.252% | -10.451% | -24.152% | -27.592% | -59.572% | - |
Galapagos NV ADR | - | -0.775% | -11.724% | -24.260% | -26.857% | -61.791% | -74.271% |
Galmed Pharmaceuticals Ltd. | -1.760% | 4.545% | 21.053% | 32.374% | -15.596% | - | - |
Generex Biotechnology | 4.940% | - | - | - | - | - | - |
Genetic Technologies Ltd. | 5.830% | -11.189% | -11.189% | 12600.000% | -13.605% | 807.143% | 3075.000% |
Genfit S.A. | -1.090% | 0.475% | -5.232% | -14.440% | -12.067% | -13.483% | -85.986% |
GenKyoTex S.A. | 0.160% | - | - | - | - | - | - |
Genmab A/S | 2.030% | -2.376% | -5.088% | -29.377% | -8.839% | -14.164% | 73.769% |
Genocea Biosciences Inc. | - | - | - | - | - | - | - |
Genomic Health | -2.270% | - | - | - | - | - | - |
Genomic Vision S.A. | -7.140% | - | - | - | - | - | - |
Genomma Lab International | 7.740% | 8.442% | -5.114% | 12.081% | 12.838% | -3.468% | 20.665% |
Genoway S.A. Inh. | 0.780% | 2.111% | -1.527% | 2.926% | -12.245% | 15.179% | 122.414% |
Genscript Biotech Corp | 1.590% | 5.556% | -22.222% | -44.699% | -41.921% | -27.322% | - |
Gensight Biologics SA | 0.380% | 2.842% | 1.660% | -31.732% | -10.158% | -95.607% | -79.206% |
Genus plc | 1.040% | -2.513% | -4.715% | -35.719% | -21.963% | -67.119% | -26.903% |
Geron Corp. | 7.910% | 2.018% | 15.924% | 64.100% | 79.776% | 183.040% | 114.554% |
Gilead Sciences Inc | 0.850% | -2.441% | -10.273% | -18.065% | -16.384% | 15.076% | 4.728% |
Global Blood Therapeutics Inc | - | - | - | - | - | - | - |
Glycomimetics Inc. | 0.130% | -15.487% | -45.331% | 23.825% | -32.389% | -28.598% | - |